Your browser doesn't support javascript.
loading
Dexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells' Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway.
Chen, Xianfeng; Hu, Juntao; Lai, Jie; Zhang, Zhiyong; Tang, Zhanhong.
Affiliation
  • Chen X; Department of Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Hu J; Department of Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Lai J; Department of Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Zhang Z; Department of Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Tang Z; Department of Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Can Respir J ; 2022: 8433960, 2022.
Article in En | MEDLINE | ID: mdl-35958433
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexmedetomidine / MicroRNAs Limits: Humans Language: En Journal: Can Respir J Year: 2022 Document type: Article Affiliation country: China Country of publication: Egypt
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexmedetomidine / MicroRNAs Limits: Humans Language: En Journal: Can Respir J Year: 2022 Document type: Article Affiliation country: China Country of publication: Egypt